CD4 and neoplasm: Kuczma et al. observed that antibiotic prophylaxis of mice treated with cyclophosphamide reduced antitumor T-cell responses, as well as led to a diminished effect of adoptive T-cell therapy, with decreased tumor-specific CD4+ T-cells [7].